n-methylscopolamine has been researched along with pk 11195 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benna, P; Bergamasco, B; Enrichens, F; Ferrero, P; Gualerzi, A; Mao, P; Olivero, G; Ravizza, L; Rocca, P | 1 |
| Bergamasco, B; Ferrero, P; Gualerzi, A; Maina, G; Ravizza, L; Rocca, P; Zanalda, E | 1 |
2 other study(ies) available for n-methylscopolamine and pk 11195
| Article | Year |
|---|---|
A study of 3H-PK 11,195 binding to "peripheral-type" benzodiazepine receptors on human lymphocytes. Evidence of decreased binding in hepatic encephalopathy.
Topics: Adult; Aged; Biomarkers; Female; Hepatic Encephalopathy; Humans; Isoquinolines; Liver Cirrhosis; Lymphocytes; Male; Middle Aged; N-Methylscopolamine; Parasympatholytics; Receptors, GABA-A; Scopolamine Derivatives | 1991 |
Peripheral-type benzodiazepine receptors in anxiety disorders.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Humans; Isoquinolines; Long-Term Care; Lymphocytes; N-Methylscopolamine; Obsessive-Compulsive Disorder; Parasympatholytics; Radioligand Assay; Receptors, GABA-A; Receptors, Muscarinic; Scopolamine Derivatives | 1991 |